Literature DB >> 1000230

Changed levels of endogenous sex steroids in women on oral contraceptives.

J M Kjeld, C M Puah, G F Joplin.   

Abstract

Serum and urinary levels of unconjugated testosterone, dihydrotestosterone, and oestradiol were measured by specific radioimmunoassays in 10 healthy women in the early follicular phase of their menstrual cycle and in nine healthy women taking oral contraceptives. The contraceptive group had testosterone levels 1-3 times higher and dihydrotestosterone levels two times higher than those in the controls. Serum oestradiol levels in the contraceptive group were much lower than those in the controls and similar to levels in postmenopausal women. The contraceptive group had about twice the urinary excretion of unconjugated (free) testosterone and dihydrotestosterone of the controls, but their excretion of unconjugated oestradiol was 2-7 times lower. The great increase in serum and urinary androgen concentrations, as well as the suppression of oestradiol, may be related to the antiovulatory effect of oral contraceptives.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1000230      PMCID: PMC1690292          DOI: 10.1136/bmj.2.6048.1354

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


  23 in total

1.  Plasma androgen levels during the menstrual cycle.

Authors:  A Vermeulen; L Verdonck
Journal:  Am J Obstet Gynecol       Date:  1976-06-15       Impact factor: 8.661

2.  Blood production and ovarian secretion rates of estradiol-17 beta and estrone in women throughout the menstrual cycle.

Authors:  D T Baird; I S Fraser
Journal:  J Clin Endocrinol Metab       Date:  1974-06       Impact factor: 5.958

3.  Simultaneous radioimmunoassay of testosterone and dihydrotestosterone.

Authors:  J M Barberia; I H Thorneycroft
Journal:  Steroids       Date:  1974-05       Impact factor: 2.668

4.  Plasma concentrations of free and non-TeBG bound testosterone in women on oral contraceptives.

Authors:  R R Tremblay; J Y Dube
Journal:  Contraception       Date:  1974-12       Impact factor: 3.375

Review 5.  Sex-hormone-binding globulin.

Authors:  D C Anderson
Journal:  Clin Endocrinol (Oxf)       Date:  1974-01       Impact factor: 3.478

6.  Plasma-aldosterone during oral-contraceptive therapy.

Authors:  R Beckerhoff; W Vetter; H Armbruster; J A Luetscher; W Siegenthaler
Journal:  Lancet       Date:  1973-06-02       Impact factor: 79.321

7.  Ovarian and adrenal contribution to peripheral androgens during the menstrual cycle.

Authors:  G E Abraham
Journal:  J Clin Endocrinol Metab       Date:  1974-08       Impact factor: 5.958

8.  Regulation of protein synthesis in chick oviduct. IV, Role of testosterone.

Authors:  R D Palmiter; M E Haines
Journal:  J Biol Chem       Date:  1973-03-25       Impact factor: 5.157

9.  Cushing's syndrome. An evaluation of the clinical usefulness of urinary free cortisol and other urinary steroid measurements in diagnosis.

Authors:  C W Burke; C G Beardwell
Journal:  Q J Med       Date:  1973-01

10.  Hormonal contraceptives and plasma sex hormone binding globulin.

Authors:  M H Briggs
Journal:  Contraception       Date:  1975-08       Impact factor: 3.375

View more
  9 in total

1.  Effect of oral contraceptives on sebum excretion rate.

Authors:  R J Pye; G Meyrick; M J Pye; J L Burton
Journal:  Br Med J       Date:  1977-12-17

2.  Oral contraceptive pill use is associated with localized decreases in cortical thickness.

Authors:  Nicole Petersen; Alexandra Touroutoglou; Joseph M Andreano; Larry Cahill
Journal:  Hum Brain Mapp       Date:  2015-04-02       Impact factor: 5.038

3.  Suppression of serum testosterone concentrations in men by an oral contraceptive preparation.

Authors:  J M Kjeld; C M Puah; B Kaufman; S Loizou; J Vlotides; G F Joplin
Journal:  Br Med J       Date:  1977-11-12

4.  Does rifampicin increase serum levels of testosterone and oestradiol by inducing sex hormone binding globulin capacity?

Authors:  M J Brodie; A R Boobis; M Gill; K Mashiter
Journal:  Br J Clin Pharmacol       Date:  1981-09       Impact factor: 4.335

5.  Effects of an oral contraceptive on sexual behavior of chimpanzees (Pan troglodytes)

Authors:  R D Nadler; J F Dahl; K G Gould; D C Collins
Journal:  Arch Sex Behav       Date:  1993-10

6.  Oral contraceptive pill use is associated with reduced odds of nonalcoholic fatty liver disease in menstruating women: results from NHANES III.

Authors:  Su-Hsun Liu; Mariana Lazo; Ayman Koteish; W H Linda Kao; Ming-Hsiung Shih; Susanne Bonekamp; Ruben Hernaez; Jeanne M Clark
Journal:  J Gastroenterol       Date:  2012-11-28       Impact factor: 7.527

7.  Regulatory T Cell Proportion and Phenotype Are Altered in Women Using Oral Contraception.

Authors:  Lachlan M Moldenhauer; Min Jin; Jasmine J Wilson; Ella S Green; David J Sharkey; Mark D Salkeld; Thomas C Bristow; M Louise Hull; Gustaaf A Dekker; Sarah A Robertson
Journal:  Endocrinology       Date:  2022-09-01       Impact factor: 5.051

8.  Intermittent nasal carriage with Staphylococcus aureus within a menstrual cycle: Results from a prospective cohort of healthy carriers.

Authors:  Su-Hsun Liu; Kuan-Fu Chen; Chih-Jung Chen; Yi-Hsiung Lin; Yhu-Chering Huang
Journal:  Medicine (Baltimore)       Date:  2016-06       Impact factor: 1.889

9.  Oral contraceptive use by formulation and endometrial cancer risk among women born in 1947-1964: The Nurses' Health Study II, a prospective cohort study.

Authors:  Norah A Burchardt; Amy L Shafrir; Rudolf Kaaks; Shelley S Tworoger; Renée T Fortner
Journal:  Eur J Epidemiol       Date:  2020-12-17       Impact factor: 8.082

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.